年龄相关性黄斑变性(AMD)与癌症发病风险之间的关联
该研究基于韩国国民健康保险服务数据库(2009-2019年)纳入2009年参加国家健康筛查的4 088 814名受试者,其中51 596例AMD患者、3 683例合并视觉障碍,平均随访9.6年。结果发现AMD组甲状腺癌(aHR 1.10,95%CI 1.00至1.20)和肾癌(aHR 1.16,95%CI 1.00至1.33)风险高于非AMD组,胃癌风险则较低(aHR 0.89,95%CI 0.84至0.94);总体癌症风险大体无显著差异。
要点
- AMD组甲状腺癌风险高于非AMD组(aHR 1.10,95%CI 1.00至1.20)。
- AMD组肾癌风险高于非AMD组(aHR 1.16,95%CI 1.00至1.33)。
- AMD组胃癌风险低于非AMD组(aHR 0.89,95%CI 0.84至0.94)。
核心结论
- 本研究显示AMD与数种癌症之间可能存在关联。
- AMD患者肾癌和甲状腺癌风险升高,可能提示AMD与多血管性癌症相关。
- 作者认为需在采用其他数据库并评估详细机制的研究中进一步验证该结果。
研究设计与样本
- 本研究为基于人群的队列研究,使用韩国国民健康保险服务数据库(2009-2019年),纳入2009年参加国家健康筛查项目的人群。
- 受试者根据是否存在AMD及视觉障碍进行分组;癌症发生依据索赔数据中《国际疾病分类第十版》编码的主要诊断确定。
- 研究采用Cox回归风险模型比较特定部位癌症的风险比(HR)。
主要发现
- 在4 088 814名参与者中,51 596例患有AMD,其中3 683例存在视觉障碍。
- 平均随访时间为9.6年;总体癌症风险大体无显著差异。
- AMD组甲状腺癌风险高于非AMD组(aHR 1.10,95%CI 1.00至1.20)。
- AMD组肾癌风险高于非AMD组(aHR 1.16,95%CI 1.00至1.33)。
- AMD组胃癌风险低于非AMD组(aHR 0.89,95%CI 0.84至0.94)。
关键数值与推荐
- 甲状腺癌:AMD组与非AMD组相比的aHR为1.10(95%CI 1.00至1.20)。
- 肾癌:AMD组与非AMD组相比的aHR为1.16(95%CI 1.00至1.33)。
- 胃癌:AMD组与非AMD组相比的aHR为0.89(95%CI 0.84至0.94)。
局限性
- 作者指出需在采用其他数据库并评估详细潜在机制的研究中进一步验证该结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: Age-related macular degeneration (AMD) and cancer may share similar risk factors, indicating possible common pathogenic pathways. We aimed to describe the site-specific cancer risk based on the relationship of AMD with visual disability (VD) status. METHODS: This was a population-based cohort study using data from the Korean National Health Insurance Service database (2009-2019) including patients who participated in a national health screening programme in 2009. The subjects were categorised based on the presence of AMD and VD. The occurrence of cancer was identified using principal diagnosis according to the International Classification of Disease, 10th revision codes in claims data. The Cox regression hazard model was used to compare HRs of site-specific cancer. RESULTS: Among 4 088 814 participants, 51 596 had AMD of which 3683 subjects had VD. The mean follow-up period was 9.6 years. The overall cancer risk was generally null, but the risk of hypervascular cancer such as thyroid cancer (adjusted HR (aHR) 1.10, 95% CI 1.00 to 1.20) and renal cancer (aHR 1.16, 95% CI 1.00 to 1.33) was higher and the risk of stomach cancer (aHR 0.89, 95% CI 0.84 to 0.94) was lower in the AMD group than in the non-AMD group. CONCLUSION: This study demonstrated a possible association between AMD and several cancers. Increased renal and thyroid cancer risk among patients with AMD could indicate that AMD is associated with hypervascular cancer. Further studies in which additional databases are used and the underlying detailed mechanisms evaluated are needed to validate our results.
引用
- Park J, Jung W, Han K, et al. Association between age-related macular degeneration and risk of incident cancer. Br J Ophthalmol. 2024. PMID: 38418207. doi:10.1136/bjo-2023-323874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。